Ignite Creation Date:
2025-12-25 @ 2:41 AM
Ignite Modification Date:
2025-12-29 @ 10:07 AM
Study NCT ID:
NCT05032833
Status:
COMPLETED
Last Update Posted:
2022-10-12
First Post:
2021-08-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects
Sponsor:
Beckley Psytech Limited
Organization:
Study Overview
Official Title:
A Double-Blind, Randomized, Phase 1, First-in-Human, Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of Intranasal 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in Healthy Subjects
Status:
COMPLETED
Status Verified Date:
2022-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study will evaluate safety, tolerability and PK profile of 5-MeO-DMT in healthy subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: